Live Breaking News & Updates on Marshall Urist

Stay updated with breaking news from Marshall urist. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Royalty Pharma : Vorasidenib Transaction Call Transcript

REFINITIV STREETEVENTS

EDITED TRANSCRIPT

RPRX.OQ - Royalty Pharma PLC To Host Investor Call

. ....

United States , Michael Difiore Evercore , Terence Flynn Morgan Stanley , Michael Difiore , Terry Coyne , Pablo Legorreta , Geoff Meacham , Terence Flynn , George Grofik , Marshall Urist , Research Investments , Morgan Stanley , Ir Communications , Susan Chor Bank , Royalty Pharma , Agios Pharmaceuticals , Equity Research Analyst , Research Division , Company Summary , Host Investor Call , Legorreta Royalty Pharma , Hite Royalty Pharma , Urist Royalty Pharma , Grofik Royalty Pharma , Flynn Morgan Stanley , Research Analyst ,

Royalty Pharma : BofA Health Care Conference Transcript

REFINITIV STREETEVENTS

EDITED TRANSCRIPT

RPRX.OQ - Royalty Pharma PLC at Bank of America Healthcare Conference
. ....

United States , Terry Coyne , Geoffrey Meacham Bof , Terrance Coyne , Marshall Urist , Geoffrey Meacham , Geoff Meacham , Research Investments , Royalty Pharma , Research Division , Head Of Research , Company Summary , America Healthcare Conference , Urist Royalty Pharma , Coyne Royalty Pharma , Meacham Bofa Securities , Im Geoff , New England Journal , Event Transcripts , All Rights ,

Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript

Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United States , Terry Coyne , Chris Schott , Geoff Meacham , Terrance Coyne , Chris Shibutani , Marshall Urist , Pablo Legorreta , George Grofik , Repros Therapeutics Inc , Goldman Sachs , Head Of Research , Royalty Pharma , Call Transcript May , Royalty Pharma First Quarter , Senior Vice President , Investor Relations , Chief Executive Officer , Chris Hite , Vice Chairman , Chief Financial , Portfolio Receipts , Royalty Receipts , New England Journal , Jim Cramer Portfolio , Repros Therapeutics ,

Royalty Pharma plc (NASDAQ:RPRX) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Third Quarter 2023 Earnings Conference Call. ....

Chris Schott , Stephen Scala , George Grofik , Christopher Schott , Andrew Baum , Marshall Urist , Pablo Legorreta , Terrance Coyne , Terry Coyne , Repros Therapeutics Inc , Life Sciences , Head Of Research , Royalty Pharma , Call Transcript November , Royalty Pharma Third Quarter , Senior Vice President , Investor Relations , Third Quarter , Chief Executive Officer , Chris Hite , Vice Chairman , Chief Financial , Cash Receipts , Adjusted Cash Flow , Adjusted Cash Receipts , Life Science ,

Royalty Pharma (NASDAQ:RPRX) Cut to "Hold" at StockNews.com

StockNews.com cut shares of Royalty Pharma (NASDAQ:RPRX – Get Rating) from a buy rating to a hold rating in a research note published on Thursday morning. RPRX has been the subject of several other reports. UBS Group dropped their price target on Royalty Pharma from $51.00 to $48.00 and set a buy rating for the […] ....

United States , Marshall Urist , Roryb Riggs , Royalty Pharma Company Profile , Blackrock Inc , Morgan Stanley , Securities Exchange Commission , Jpmorgan Chase Co , Baillie Gifford Co , Vanguard Group Inc , Royalty Pharma , Get Rating , Moderate Buy , Exchange Commission , Director Rory , State Street Corp , Street Corp , Royalty Pharma Daily , Nasdaq Rprx , Stocknews Com ,